Pharmaceutical Technology

JULY 12, 2022

GlobalData views the ALL pipeline as unsustainable given the rarity of the disease and, unfortunately, most of the pipeline CAR-T cell products for ALL will never reach the market due to strategic decisions, potentially prioritizing other cancers. The total market for cell therapies in oncology is projected to exceed $37bn worldwide by 2028.

Leads 52

Leads Food and Drug Administration Marketing Sales 52

Pharmaceutical Technology

APRIL 13, 2023

Following the increased use of telemedicine during the Covid-19 pandemic, the potential of digital technologies in communication, data collection, and analysis has become increasingly realised by patients, healthcare systems, and clinical trial sponsors.

Food and Drug Administration 52

Food and Drug Administration Electronics Healthcare Healthcare 52

Medgadget

JULY 10, 2023

The captured bacteria can be assessed visually, providing a simple yes/no diagnosis, and the purified sample can also be characterized in a lab for more in-depth analysis. The chip uses dielectrophoresis to capture the bacteria based on their dielectric properties, whereas other bacteria and impurities in the sputum sample are washed away.

Training 57

Training Patients Medicine 57

Legacy MEDSearch

SEPTEMBER 5, 2023

About Techsomed Techsomed is a global medical imaging software company dedicated to making an enhanced clinical impact in Oncology, Cardiology and Pain Management through the first Gen-AI powered Image Guided Ablation Therapy System. “We are excited to receive 510(k) clearance for our VisAble.IO

FDA 52

FDA Food and Drug Administration Physicians Recruitment 52

Clarivate

DECEMBER 16, 2021

I work on providing epidemiological analysis and disease forecasting across a range of diseases, such as oncology, chronic diseases, hospital infectious diseases, and more. In a broader view, many female health worker and researcher leaders have been playing crucial roles especially during the pandemic. Yes, absolutely.

Specialization 98

Specialization Doctors Medicine 98

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. Grand View Research Pharmacovigilance market predictions: Source Monitoring the safety of cancer medicines is crucial, giving rise to the market with the oncology segment of 26.9% billion during 2020-2024.

Pharma 52

Pharma Medicine Marketing Prospecting 52

European Pharmaceutical Review

DECEMBER 6, 2022

To ensure applicability for the future, these applications were excluded from our analysis. Of the remaining 11, most products submitted for early access were oncology drugs and two products, Adtralza and Rinvoq, for atopic dermatitis 3. Of these, six concerned COVID-19 medications and were submitted in exceptional circumstances.

Patients 88

Patients Manufacturing Safety Healthcare 88

pharmaphorum

JANUARY 27, 2023

Physicians and staff have a significant responsibility to maintain the quality of a trial through important procedures, including patient chart analysis, to grasp key insights that will have an impact on patient care decisions. The post Tackling ongoing staffing burnout rates through AI-enabled precision oncology appeared first on.

Physicians 98

Physicians Healthcare Healthcare Patients 98

pharmaphorum

OCTOBER 17, 2022

Their success led to the discovery of an entirely new principle for cancer therapy – the field of immuno-oncology – one that is now a mainstay of cancer treatment, changing the way these diseases can be managed. Dr. Marie-Louise Fjällskog has over 30 years of experience in clinical oncology, translational research, and drug development.

Recruitment 97

Recruitment Patients Leads Medicine 97

pharmaphorum

NOVEMBER 17, 2022

Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology. As medical treatments become more complex, the role of the Medical Science Liaison (MSL) has never been more important.

Training 104

Training Digital Media Medical Media 104

pharmaphorum

SEPTEMBER 8, 2022

It is a similar approach to that of another form of oncology treatment that is also experiencing a surge of interest, antibody-drug conjugates (ADCs). The post Are radiopharmaceuticals the next breakthrough in oncology? Once in the body, the targeting molecule can deliver the radioactive molecule to the cancer cells.

Manufacturing 93

Manufacturing Pharma Side effects Patients 93

pharmaphorum

DECEMBER 22, 2022

From a prevention point of view, she continued, it is important to look at the variation between EU member states. For example, HPV vaccine rates in Malta are 97%; in Bulgaria, they are 2%.

Food 88

Food Patients Networking Distribution 88

pharmaphorum

SEPTEMBER 30, 2022

Novel oncologic drugs continue to command premium pricing, driven by a combination of unmet needs, and delivering often-iterative, sometimes-significant improvements in survival or maintenance of a progression-free state. The post Low-Priced Oncology Disruptors: The Cuckoo in the PD-1/PD-L1 Nest or the Runt of the Clutch?

Consulting 80

Consulting Marketing Pharma Manufacturing 80

pharmaphorum

DECEMBER 20, 2022

Oncology trial starts reached historic highs in 2021, and a record 30 oncology novel active substances were launched globally the same year, according to research by IQVIA. In recent years, those involved in the research and development of new oncology treatments have delivered ground-breaking therapies.

Leads 83

Leads Patients Recruitment Consulting 83

pharmaphorum

JULY 6, 2022

A new cross-sectional study has found that the FDA green lit 95% of the 89 new oncology therapies approved between 2010 and 2019 before the EMA, with the Europeans trailing the Americans by a median of 241 days. The past decade has seen huge advances in cancer therapy, with a swathe of first-in-class or breakthrough therapies being developed.

Safety 91

Safety FDA Medicine Patients 91

pharmaphorum

DECEMBER 19, 2022

Nonetheless, resources only explain part of the differences in oncological performance, she said. Rizvi replied that there aren’t large-scale studies or a crisis analysis plan in Europe for oncology. times more likely to be taken up by higher-income people). Crisis and cancer control. Fitzgerald opened the discussion.

Patients 75

Patients Healthcare Healthcare Management 75

pharmaphorum

SEPTEMBER 27, 2022

As new and effective innovations emerge, particularly in an area of acute need, such as oncology, the financial rewards for such treatments are rich. Another advantage that Halioua raised is one that many are looking at: the synergy between cancer vaccines and current checkpoint inhibitor treatments. billion.

Leads 77

Leads Sales Patients Pharma 77

pharmaphorum

JANUARY 19, 2023

This could be a major step forward for immuno-oncology therapy, or, as Chopra puts it, “another pillar in our armamentarium against cancer”. View the video below and stay tuned for more live chats from JP Morgan Week. Chopra also talks a little bit about plans so far for the future of Aethon.

Medicine 79

Medicine Patients 79

pharmaphorum

OCTOBER 27, 2022

Last month, pharmaphorum had the chance to speak with Dr Isabelle Ray-Coquard, professor of medical oncology (specialism sarcomas and GISTs) at the Centre Léon Bérard (CLB), a hospital 100% dedicated to cancer care and research. Ovarian cancer in Europe, the UK, and beyond.

Patients 68

Patients Leads Specialization Networking 68

pharmaphorum

NOVEMBER 9, 2022

Kyriakides told us that the importance of partnerships and solidarity, and Europe’s very cancer plan, is built on the powerful premise of the strength that comes in working together: such is a quintessentially European view of policy making.

Insurance 87

Insurance Patients Healthcare Healthcare 87

pharmaphorum

AUGUST 18, 2022

Last month in Chicago, Illinois the American Society of Clinical Oncology hosted its first in-person meeting since the COVID-19 pandemic began. Led by Merck’s blockbuster Keytruda, these drugs have been making waves in the oncology space for some time, and this year’s ASCO kept up that trend.

Patients 52

Patients 52

pharmaphorum

NOVEMBER 10, 2022

To continue with pharmaphorum’s coverage of Day One of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium this week – where the foci were “innovation, equity, and excellence” – after the opening addresses came a panel on the priorities for innovation and excellence in cancer care within Europe.

Electronics 78

Electronics Government Patients Pharma 78

pharmaphorum

AUGUST 4, 2022

Over the past two decades, innovative research efforts, such as the Human Genome Project and 100,000 Genomes Project, have vastly expanded our understanding of the human genome and its role in driving research and development in oncology. The post Realising the promise of genomic testing across oncology appeared first on.

Marketing 52

Marketing Patients 52

pharmaphorum

JANUARY 5, 2023

During The Economist’s 8th Annual World Cancer Series congress in Brussels November last year, web editor Nicole Raleigh sat down to discuss the event and its themes with Greg Rossi, senior vice president, head of oncology Europe and Canada at AstraZeneca.

Patients 52

Patients Physicians Management 52

pharmaphorum

JULY 26, 2022

For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. And for good reason. The concept of pre-emptively training the immune system to increase the frequencies of tumour-reactive T cells could be game-changing for cancer patients worldwide.

Training 52

Training Patients 52

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives.

Side effects 52

Side effects Patients Medical Medicine 52

pharmaphorum

OCTOBER 20, 2022

The European Society for Medical Oncology (ESMO) Congress 2022 in Paris returned with an in-person format in September, its first since the pandemic, along with a virtual option. The reactions and insights from ESMO 2022 oncology attendees provide a simple takeaway for life science manufacturers: their work is essential.

Medical 52

Medical Patients Marketing Medicine 52

pharmaphorum

OCTOBER 13, 2022

In this episode of the pharmaphorum podcast series, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health.

Management 52

Management Pharma Consulting Education 52

pharmaphorum

OCTOBER 6, 2022

Many of these challenges are exacerbated in oncology, where the treatment landscape rapidly evolves with novel mechanisms of actions (e.g., Strategic planning and early investments in HCP and patient education are critical success factors for small and emerging companies launching oncology products.

Education 52

Education Healthcare Provider Physicians Competition 52

pharmaphorum

AUGUST 25, 2022

Cancer vaccines are a major part of how the oncology space is evolving, and technology like AI is supercharging that evolution. Tune in to learn more. . You can listen to episode 58 of the? pharmaphorum podcast ?in in the player below, download the episode to your computer or find it – and subscribe to the rest of the series in?

52

52

pharmaphorum

DECEMBER 9, 2022

Jack and John tell Jonah about the emerging area of targeted radiotherapeutics and how their company is combining that technology with mathematical modelling to optimise this exciting new area of oncology care. .

Marketing 64

Marketing Patients 64

pharmaphorum

JANUARY 27, 2023

pharmaphorum editor-in-chief Jonah Comstock joins Adi Hoess, CEO of Affimed Therapeutics, at their JPM2023 headquarters at the Zeppelin Hotel, to learn about Affimed’s work and their plans for the year to come.

Manufacturing 59

Manufacturing Patients 59

pharmaphorum

DECEMBER 29, 2022

As we close out the year, pharmaphorum’s editorial team sat down together for a roundtable discussion of some of the biggest trends they tracked this year in the world of pharma. .

Pharma 52

Pharma Medicine Patients Marketing 52

pharmaphorum

OCTOBER 6, 2022

As our understanding of oncology has increased, it’s become clear that each cancer consists of much more than just the tumour cell – a whole ecosystem of vessels, immune cells, and connective tissues form the tumour micro-environment (TME).

Medical 52

Medical Patients Pharmaceutical 52

InCrowd

AUGUST 18, 2022

This transition marks a pronounced epidemiological shift, where oncological diseases will become the number one cause of death worldwide. Cancer is viewed as insidious and relentless, the king of human suffering. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry.

Side effects 52

Side effects Leads Training Medicine 52

Clarivate

MAY 6, 2022

The analysis is led by David Pendlebury , Head of Research Analysis, and myself, Ryan Fry, Senior Product Data Analyst. Our analysis of SDG 3 papers and the 2021 recipients of our Highly Cited Researchers program produced a list of 1,900 individuals and 10,900 Highly Cited Papers published in these areas. About the authors.

Education 98

Education Medicine Training Government 98

Pharmaceutical Technology

SEPTEMBER 14, 2022

This week, at the European Society of Medical Oncology (ESMO) Congress 2022 researchers presented encouraging updates on immunotherapies in the field of cervical cancer. Phase III long-term survival analysis of Libtayo. There is a deep need to keep having this broader view”. Phase I/II Checkmate-358 trial.

Food and Drug Administration 59

Food and Drug Administration Patients FDA Pharmaceutical 59